ShockWave Medical, Inc. (SWAV)

ShockWave Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	163.5	147.28	216	-9.14	-65.7	-51.11
Depreciation & Amortization	15.06	13.52	7.9	5.54	3.35	2.28
Share-Based Compensation	80.2	73.23	44.89	27.26	10.35	3.65
Other Operating Activities	-60.83	-37.98	-151.05	-8.62	-19.18	-2.93
Operating Cash Flow	197.93	196.05	117.73	15.04	-71.18	-48.11
Operating Cash Flow Growth	32.17%	66.52%	683.00%	-	-	-
Capital Expenditures	-31.8	-30.6	-25.13	-12.44	-11.52	-3.82
Acquisitions	-94.41	-94.41	0	0	0	0
Change in Investments	-590.16	-500.72	-37.02	38.86	-95.95	-55.73
Investing Cash Flow	-716.36	-625.73	-62.15	26.42	-107.47	-59.54
Share Issuance / Repurchase	9.21	7.6	7.05	5.89	89.48	209.72
Debt Issued / Paid	529.08	609.08	5.97	0	2.15	-1.67
Other Financing Activities	-16.29	-16.28	-0.02	-8.34	-1.6	-
Financing Cash Flow	522	600.4	13	-2.45	90.04	208.05
Exchange Rate Effect	-3.17	0.8	-1.15	0	0	0
Net Cash Flow	0.4	171.52	67.43	39	-88.62	100.4
Free Cash Flow	166.14	165.46	92.61	2.6	-82.7	-51.92
Free Cash Flow Growth	37.61%	78.67%	3465.88%	-	-	-
Free Cash Flow Margin	21.08%	22.66%	18.91%	1.10%	-122.00%	-120.96%
Free Cash Flow Per Share	4.46	4.51	2.58	0.07	-2.50	-2.17

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).